The present invention discloses a pharmaceutical composition comprising at least one bioactive substance and at least one neutral salt consisting of a polyamino-saccharide cation and an anion, for use in the treatment of articular tissues affected by arthropathies, wherein said pharmaceutical composition reduces expression of the key receptors involved in the genesis the inflammatory cascade and efficaciously maintains performance for a prolonged period of time.